48 related articles for article (PubMed ID: 12882972)
1. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
[TBL] [Abstract][Full Text] [Related]
2. The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice.
Georgopoulos S; Kan HY; Reardon-Alulis C; Zannis V
Nucleic Acids Res; 2000 Dec; 28(24):4919-29. PubMed ID: 11121483
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice.
Wilhelm AJ; Zabalawi M; Owen JS; Shah D; Grayson JM; Major AS; Bhat S; Gibbs DP; Thomas MJ; Sorci-Thomas MG
J Biol Chem; 2010 Nov; 285(46):36158-69. PubMed ID: 20833724
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein-mediated regulation of lipid metabolism induces distinctive effects in different types of breast cancer cells.
Ben Hassen C; Gutierrez-Pajares JL; Guimaraes C; Guibon R; Pinault M; Fromont G; Frank PG
Breast Cancer Res; 2020 Apr; 22(1):38. PubMed ID: 32321558
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NF-kappa B by sodium salicylate and aspirin.
Kopp E; Ghosh S
Science; 1994 Aug; 265(5174):956-9. PubMed ID: 8052854
[TBL] [Abstract][Full Text] [Related]
6. Aspirin increases apolipoprotein-A-I-mediated cholesterol efflux via enhancing expression of ATP-binding cassette transporter A1.
Wang YH; Chen YF; Chen SR; Chen X; Chen JW; Shen XY; Mou YG; Liu PQ
Pharmacology; 2010; 86(5-6):320-6. PubMed ID: 21088444
[TBL] [Abstract][Full Text] [Related]
7. An overview of reverse cholesterol transport.
Tall AR
Eur Heart J; 1998 Feb; 19 Suppl A():A31-5. PubMed ID: 9519340
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease.
Fuior EV; Zvintzou E; Filippatos T; Giannatou K; Mparnia V; Simionescu M; Gafencu AV; Kypreos KE
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893070
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lipid profile in adult hemophagocytic lymphohistiocytosis.
Cheng W; Wang L; Gao X; Duan L; Shu Y; Qiu H
Front Oncol; 2023; 13():1083088. PubMed ID: 36895490
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Daily Methylsulfonylmethane (MSM) Consumption on High-Density Lipoprotein Cholesterol in Healthy Overweight and Obese Adults: A Randomized Controlled Trial.
Miller L; Thompson K; Pavlenco C; Mettu VS; Haverkamp H; Skaufel S; Basit A; Prasad B; Larsen J
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684621
[TBL] [Abstract][Full Text] [Related]
11. Short-Chain Fatty Acids (Except Hexanoic Acid) Lower NF-kB Transactivation, Which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells.
Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mokhtar FBA; Plat J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708494
[TBL] [Abstract][Full Text] [Related]
12. Hydroxytyrosol Plays Antiatherosclerotic Effects through Regulating Lipid Metabolism via Inhibiting the p38 Signal Pathway.
Zhang X; Qin Y; Wan X; Liu H; Iv C; Ruan W; Lu L; He L; Guo X
Biomed Res Int; 2020; 2020():5036572. PubMed ID: 32685494
[TBL] [Abstract][Full Text] [Related]
13. The Mechanism of Bisphenol A Atherogenicity Involves Apolipoprotein A-I Downregulation through NF-κB Activation.
Trusca VG; Dumitrescu M; Fenyo IM; Tudorache IF; Simionescu M; Gafencu AV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842455
[TBL] [Abstract][Full Text] [Related]
14. Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA.
Shao D; Lian Z; Di Y; Zhang L; Rajoka MSR; Zhang Y; Kong J; Jiang C; Shi J
NPJ Sci Food; 2018; 2():13. PubMed ID: 31304263
[TBL] [Abstract][Full Text] [Related]
15. Novel candidate genes important for asthma and hypertension comorbidity revealed from associative gene networks.
Saik OV; Demenkov PS; Ivanisenko TV; Bragina EY; Freidin MB; Goncharova IA; Dosenko VE; Zolotareva OI; Hofestaedt R; Lavrik IN; Rogaev EI; Ivanisenko VA
BMC Med Genomics; 2018 Feb; 11(Suppl 1):15. PubMed ID: 29504915
[TBL] [Abstract][Full Text] [Related]
16. FOXO1 and LXRα downregulate the apolipoprotein A-I gene expression during hydrogen peroxide-induced oxidative stress in HepG2 cells.
Shavva VS; Bogomolova AM; Nikitin AA; Dizhe EB; Oleinikova GN; Lapikov IA; Tanyanskiy DA; Perevozchikov AP; Orlov SV
Cell Stress Chaperones; 2017 Jan; 22(1):123-134. PubMed ID: 27896567
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of ApoA1 after neuronal injury may be beneficial for healing.
Sengupta MB; Saha S; Mohanty PK; Mukhopadhyay KK; Mukhopadhyay D
Mol Cell Biochem; 2017 Jan; 424(1-2):45-55. PubMed ID: 27734225
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.
Wang Y; Liu J; Jiang Y; Zhang H; Leng S; Wang G
BMC Cardiovasc Disord; 2016 Jan; 16():10. PubMed ID: 26758372
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.
Sharifov OF; Xu X; Gaggar A; Grizzle WE; Mishra VK; Honavar J; Litovsky SH; Palgunachari MN; White CR; Anantharamaiah GM; Gupta H
PLoS One; 2013; 8(5):e64486. PubMed ID: 23691230
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic interventions to enhance apolipoprotein A-I-mediated cardioprotection.
Haas MJ; Mooradian AD
Drugs; 2010 May; 70(7):805-21. PubMed ID: 20297868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
